UK facial biometric firm iProov chosen to help US Department of Homeland Security to enhance and secure cross-border passenger travel
iProov, a leading provider of biometric facial verification technology, today announced it has become the first British – and indeed overseas – company to be awarded a contract from the US Department of Homeland Security Science & Technology Directorate’s Silicon Valley Innovation Program (SVIP).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180416006084/en/
iProov CEO, Andrew Bud (Photo: Business Wire)
The contract has been awarded to iProov to help US Customs and Border Protection (CBP) improve the passenger entry operation process.
London-based iProov was founded in 2011 by CEO Andrew Bud. The company’s facial biometric technology, patented in the US and UK, is used by banks and governments around the world for secure customer onboarding, logon and authentication, to ensure new and returning users are genuine and guard against fraudulent attempts to gain access to personal data or use a stolen identity.
The contract iProov has won will see the company develop technology that aims to enhance cross-border passenger travel at unmanned ports of entries while reducing processing time. It could help US CBP quickly, accurately and reliably identify travellers as they process through US border crossings.
At the heart of this announcement is iProov’s Flashmark technology, deployed in its secure, cloud-based facial biometric verification system that can be accessed via a user’s mobile phone. In this case, iProov’s technology will work with existing CBP systems, on which travellers’ details are pre-registered. In the run up to arrival at the US border, whether at home or en route, travellers would be able to self-serve the document check that normally happens at the point of border crossing, by authenticating themselves securely to their pre-registered photo, via their mobile phone. The process is simple, much quicker than waiting in line, and more secure than traditional methods.
Dr. Liam Fox, Secretary of State for the UK Department for International Trade, commented, “The UK and US are world leaders in cyber security. Through close cooperation across various sectors, trade between the two countries has grown to £181.2 billion pounds in 2017 - making the US our largest trading partner and biggest export market.
“One example of our shared economic and security ties is UK based iProov technology, which uses cutting-edge facial biometric verification technology to enhance security and deter those who seek to cause harm. It is now used by a range of institutions across the world and will soon be used by the US Customs and Border Protection, helping to enhance the way it processes people through US borders.”
The reason iProov was selected comes down to its ability to detect ‘spoofs’. In a self-serve identity verification environment, the system must be able to confirm whether or not the person presenting themselves for verification is genuinely the owner of the ID credential, not a photo, screen image or doctored video. iProov has ten granted patents in the UK and US for the technology that can detect these spoofs, and in this way is uniquely able to help governments tackle the pressure they are under from increased traveller numbers to swiftly but securely verify each and every traveller.
It is this growth in international travel which led the DHS S&T Directorate’s SVIP to look for partners to help tackle the cross-border passenger entry operation process. Over 112 million passengers enter the United States annually and over 1 million attempt to pass through its borders each day, increasing the pressure on Customs and Border Protection to facilitate the entry of international visitors, increase tourism and foster economic growth while ensuring the highest level of security.
iProov’s CEO, Andrew Bud, who will be speaking about the contract win while part of a UK trade delegation with the UK’s Department for International Trade to global cyber security conference RSA in San Francisco, commented, “We are delighted that iProov has been selected by the US Department of Homeland Security to enhance the way in which it processes people through US borders. Advances in machine learning and AI have enabled a revolution in facial biometrics in the last few years and we’re now seeing more and more cases of governments and banks turning to self-service, spoof-resilient face verification as the biometric of choice to both increase security and ensure ease of use.”
This is not the first time iProov has been recognised for its industry leading identity verification technology. The company won the 2017 National Cyber Security Centre’s Cyber Dragon’s Den competition at CYBERUK 2017; it has received a number of grants from Innovate UK, the UK's innovation agency; and in September 2017 was named the sole UK member of the SINET16, a select group of cyber-security innovators. In the financial services sector its technology is in live use with banks such as DNB in Norway and Rabobank in the Netherlands.
Founded in 2011 by CEO Andrew Bud, iProov is a world leader in spoof-resistant, biometric facial verification technology. Its technology is used by banks and governments around the world for secure customer onboarding, logon and authentication, to ensure new and returning users are genuine and guard against fraudulent attempts to gain access to personal data or use a stolen identity. For more information, please see www.iproov.com
+44 7833 474 447
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Abu Dhabi to Host Interfaith Alliance For Safer Communities: Child Dignity in the Digital World Forum on 19 November17.11.2018 13:40 | Pressemelding
Held under the patronage of His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, the UAE will host the first edition of the Interfaith Alliance For Safer Communities Forum on November 19-20 in recognition of the country’s leading role in promoting tolerance and interfaith dialogue. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181117005008/en/ His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces (Photo: AETOSWire) The forum will host 450 guests including religious leaders, NGOs and heads of industry to discuss ongoing social challenges and develop comprehensive solutions for protecting youth from cybercrime. The Interfaith Alliance For Safer Communities Forum is an expansion of the Child Dignity in the Digital World Congress which was held in October 2017 in the Vatican, an
Philip Morris International and Dorna Switch Gears in Quest for a World without Tobacco Smoke17.11.2018 11:00 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE:PM) and Dorna Sports S.L., the commercial rights holder for the world FIM MotoGP Championships, have extended their partnership until the end of 2021. The two organizations have collaborated successfully for 26 years. As of 2019, the partnership will focus on advancing the cause of a smoke-free world. More than 1 billion people smoke today and, according to the World Health Organization, will continue to smoke in the near future. PMI has committed to transform its business and encourage all men and women who would otherwise continue smoking to replace cigarettes with better alternatives as soon as possible. With around 350 million MotoGP fans worldwide, MotoGP can play a significant role in positively impacting the lives of people who smoke and those around them. “The best choice for consumers concerned about the health risks of smoking is to quit tobacco and nicotine altogether. Today, however, technology, science and innovation provide a r
Schlumberger Announces Fourth-Quarter and Full-Year 2018 Results Conference Call16.11.2018 18:00 | Pressemelding
Schlumberger Limited (NYSE:SLB) will hold a conference call on January 18, 2019 to discuss the results for the fourth quarter and full year ending December 31, 2018. The conference call is scheduled to begin at 8:30 am US Eastern time and a press release regarding the results will be issued at 7:00 am US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 288-8967 within North America or +1 (612) 333-4911 outside of North America approximately 10 minutes prior to the start of the call, and ask for the “Schlumberger Earnings Conference Call.” A webcast of the conference call will be broadcast simultaneously at www.slb.com/irwebcast on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until February 18, 2019, and can be accessed by dialing +1 (800)
Visa Strengthens Commitment to Growing Digital Payments in India16.11.2018 14:33 | Pressemelding
Visa (NYSE: V) today announced a minority investment in BillDesk, a leading platform for online payments and bill payments in India. Visa’s investment and collaboration will help BillDesk develop new product lines for its payments and loyalty businesses and also expand its footprint into other geographies. The investment will be subject to necessary statutory approvals and is expected to have no direct bearing on Visa’s existing Indian business. “As a leading payments player in India, BillDesk has been a long time business partner to Visa. Having worked with BillDesk’s founders over the years, the Visa leadership has been consistently impressed with their vision, market knowledge and execution capabilities, as well as alignment on values. This investment further reinforces our long-term commitment to India’s digital payments growth story,” said Asia Pacific regional president, Chris Clark. “We are truly excited by this investment from the world's largest global payment network, Visa. W
Guidewire Enhances PartnerConnect Consulting Program with Addition of Product and Regional Specializations16.11.2018 13:55 | Pressemelding
Guidewire Software, Inc. (NYSE: GWRE), provider of the industry platform Property and Casualty (P&C) insurers rely upon, today announced the addition of specializations to its PartnerConnect Consulting program. Specializations have been added to aid insurance companies in selecting the best partner to lead or staff their Guidewire projects. Guidewire unveiled new specializations, including two which have been successfully piloted earlier this year. “Our customers will now have more clarity and information as to which partners have the proven capabilities in their chosen product and region,” said Lisa Walsh, vice president, Alliances, Guidewire Software. “Adding these specializations will also allow us to have more insight into a partner’s performance and competencies.” To earn a specialization, partners need to demonstrate skills, knowledge, and competency in a specific Guidewire product or solution by certifying staff at multiple levels (specialist and professional) through Guidewire’
Janssen receives positive CHMP opinion for ERLEADA™ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer who are at high risk of developing metastatic disease16.11.2018 13:15 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for apalutamide, a next generation oral androgen receptor inhibitor for the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease.2 The CHMP’s positive opinion will now be reviewed by the European Commission (EC), which has the authority to grant approval for the use of apalutamide. The CHMP’s positive opinion is based on data from the pivotal SPARTAN Phase 3 clinical study which assessed the safety and efficacy of apalutamide versus placebo in patients with nmCRPC who have a rapidly rising prostate specific antigen (PSA) level despite receiving continuous androgen deprivation therapy (ADT). The SPARTAN clinical study showed that apalutamide, when added to ADT, significantly reduced the risk